Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/219051
Antioxidant therapeutic strategies in neurodegenerative diseases
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
The distinguishing pathogenic features of neurodegenerative diseases include mitochondrial dysfunction and derived reactive oxygen species generation. The neural tissue is highly sensitive to oxidative stress and this is a prominent factor in both chronic and acute neurodegeneration. Based on this, therapeutic strategies using antioxidant molecules towards redox equilibrium have been widely used for the treatment of several brain pathologies. Globally, polyphenols, carotenes and vitamins are among the most typical exogenous antioxidant agents that have been tested in neurodegeneration as adjunctive therapies. However, other types of antioxidants, including hormones, such as the widely used melatonin, are also considered neuroprotective agents and have been used in different neurodegenerative contexts. This review highlights the most relevant mitochondrial antioxidant targets in the main neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, and Huntington's disease and also in the less represented amyotrophic lateral sclerosis, as well as traumatic brain injury, while summarizing the latest randomized placebo-controlled trials.
Subject (English)
Citation
Citation
MORÉN NÚÑEZ, Constanza, et al. Antioxidant therapeutic strategies in neurodegenerative diseases. International Journal of Molecular Sciences. 2022. Vol. 23, num. 16. ISSN 1661-6596. [consulted: 15 of June of 2026]. Available at: https://hdl.handle.net/2445/219051